2026 Reports — Aflac

Aflac's Q1 2026 net earnings jumped to $1.02 billion from $29 million on a $1.0 billion swing in investment gains and a 16.8% tax rate, while adjusted earnings slipped 0.6% and Japan posted 25.5% yen sales growth on its new Anshin Palette medical product.

Aflac's reported profit rose 38% on shrinking investment losses and a 17% tax rate, while adjusted earnings fell 7.7% — a 6.1% smaller share count, not premium growth, is what held EPS roughly flat.